BS

Bhavesh Sharad Maidankar

Active Director Director DIN 10586819
DIN 10586819 First appointment Apr 2024 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhavesh Sharad Maidankar

Data last updated:

Bhavesh Sharad Maidankar is a Director at Rbr Pharmaceutical Private Limited (since 2024). The company operates in Pharma.

DIN 10586819
Primary Designation Director
Industry Pharma
First Appointment 10 Apr 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Rbr Pharmaceutical Private Limited U46497MH2024PTC423279
Director10 Apr 20242024Active

Board colleagues of Bhavesh Sharad Maidankar

Directorship timeline

Open interactive timeline →
Rbr Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Bhavesh Sharad Maidankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhavesh Sharad Maidankar

Bhavesh Sharad Maidankar currently holds 1 directorship: Rbr Pharmaceutical Private Limited (Director, since 10 Apr 2024).

Bhavesh Sharad Maidankar was first appointed on 10 Apr 2024 as Director at Rbr Pharmaceutical Private Limited.

The current boards of Bhavesh Sharad Maidankar's companies include Rushikesh Sahebrao Sawarkar (Rbr Pharmaceutical Private Limited), Rutik Gopalrao Malpe (Rbr Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available